Stanley Robert Bushby

Stanley Robert Bushby is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of microbial systems and infections through his innovative patents. With a total of 3 patents, Bushby has focused on developing formulations that enhance the effectiveness of treatments against microbial infections.

Latest Patents

Bushby's latest patents include a composition for testing or treating microbial systems or infections. This composition comprises an effective potentiating amount of a microbial dihydropteridine antagonist, which inhibits hydroxymethyldihydropteridine pyrophospokinase and has low toxicity. It is combined with an effective amount of a competitor of para-aminobenzoic acid or an inhibitor of dihydrofolate reductase, or both. This invention is aimed at inhibiting the production of dihydrofolic acid by microorganisms under in vivo or in vitro conditions. Another significant patent is the stabilized thymidine phosphorylase formulation, which improves a bacterial culture medium used in testing for the susceptibility of bacteria to anti-folate and anti-bacterial agents by incorporating purified thymidine phosphorylase of bacterial origin.

Career Highlights

Bushby has been associated with Burroughs Wellcome Co., where he has applied his expertise in developing innovative solutions for microbial infections. His work has contributed to advancements in the pharmaceutical industry, particularly in the area of anti-infective agents.

Collaborations

Throughout his career, Bushby has collaborated with notable colleagues such as Thomas A Krenitsky and James J Burchall. These collaborations have further enhanced the impact of his inventions in the field.

Conclusion

Stanley Robert Bushby is a distinguished inventor whose work has significantly advanced the understanding and treatment of microbial infections. His innovative patents reflect his commitment to improving health outcomes through scientific research and development.